PEMT: The Gene That Determines Whether Your Liver Can Make Its Own Choline
Choline isn't just a dietary nutrient — it's something your liver should be synthesizing. If you carry the PEMT rs7946 variant, that synthesis is severely impaired. The consequences ripple through liver function, brain health, muscle integrity, and fetal development.
The Core Finding
PEMT (phosphatidylethanolamine N-methyltransferase) converts phosphatidylethanolamine into phosphatidylcholine in the liver — generating roughly 30% of the body's choline supply endogenously. The rs7946 variant (G→A, Val→Met at codon 175) reduces this enzymatic activity by 50–70%. In premenopausal women, estrogen normally upregulates PEMT expression to compensate — but this protection disappears after menopause, during pregnancy complications, or when estrogen signaling is impaired. The result: variant carriers are dependent on dietary choline at levels most people never reach.
What PEMT Does — and Why Choline Isn't Just a Nutrient
Choline is classified as an essential nutrient, but the word "essential" in nutrition technically means "cannot be sufficiently synthesized — must come from diet." That classification is misleading in the context of PEMT, because for most people, the liver does synthesize meaningful quantities.
PEMT catalyzes a three-step methylation reaction: it adds three methyl groups (donated by SAMe — S-adenosylmethionine) to phosphatidylethanolamine (PE), converting it stepwise to phosphatidylcholine (PC). PC is the dominant phospholipid in cell membranes and is the primary carrier for choline throughout the body. Without adequate PC synthesis:
- VLDL secretion fails: The liver requires PC to package and export triglycerides as VLDL. Without it, fat accumulates — this is the direct mechanism behind PEMT-related non-alcoholic fatty liver disease (NAFLD).
- Cell membrane fluidity drops: Every cell membrane is ~50% phosphatidylcholine. Impaired synthesis affects membrane integrity, especially in rapidly dividing cells.
- Acetylcholine synthesis is limited: The brain synthesizes the neurotransmitter acetylcholine from choline. Memory formation, attention, and neuromuscular signaling all depend on adequate choline supply.
- Methyl group demand increases: Because PEMT consumes SAMe, impaired PEMT activity changes methylation economy — relevant for anyone also carrying MTHFR variants (see interaction section below).
The PEMT pathway accounts for approximately 30% of hepatic choline production in healthy individuals. For PEMT rs7946 carriers, that contribution drops substantially — shifting the burden entirely onto dietary intake.
PEMT rs7946: The Variant and Its Population Frequency
The primary clinically significant PEMT SNP is rs7946 (G>A; Val175Met). Located in exon 8 of the PEMT gene on chromosome 17q21, this missense mutation replaces a valine with a methionine at position 175 of the enzyme.
PEMT rs7946 — Population Frequencies
| Ancestry | A allele frequency | ~% AA homozygotes |
|---|---|---|
| European | ~21% | ~4–5% |
| South Asian | ~18% | ~3–4% |
| East Asian | ~14% | ~2% |
| African | ~12% | ~1–2% |
In European populations, approximately 38–40% carry at least one A allele (GA heterozygotes + AA homozygotes). While AA homozygotes show the most pronounced effect, GA heterozygotes also demonstrate measurably increased choline requirements — the effect is partially dominant, not strictly recessive.
The founding research by Da Costa et al. (2006) demonstrated that 77% of premenopausal women on a low-choline diet who developed organ dysfunction (fatty liver or muscle damage) were PEMT rs7946 carriers — compared with a much lower proportion of variant-free women on the same diet.
The Estrogen Connection: Why PEMT Is Primarily a Women's Issue
One of the most clinically important aspects of PEMT biology is its relationship with estrogen. The PEMT gene promoter contains functional estrogen response elements — meaning estrogen directly upregulates PEMT expression. This has two major implications:
Premenopausal protection: In women with normal estrogen levels, PEMT expression is elevated enough that even the rs7946 variant often doesn't cause clinical problems — estrogen partially rescues activity. This is why many variant carriers don't realize they have an issue until their estrogen declines.
Menopause vulnerability: As estrogen drops, PEMT upregulation disappears. Postmenopausal women with rs7946 lose both the estrogen rescue and their endogenous synthesis capacity simultaneously. This is when NAFLD risk, cognitive decline, and muscle symptoms often become apparent.
Men and postmenopausal women are equally vulnerable: Men and postmenopausal women have equivalent PEMT activity levels (without the estrogenic boost), which means rs7946 creates similar choline requirements regardless of biological sex — once the hormonal buffer is gone.
Pregnancy demands: Fetal development requires massive choline for neural tube closure, brain development, and placental function. During pregnancy, choline transfer to the fetus can deplete maternal stores rapidly. PEMT carriers who are pregnant face a compound demand: their own reduced synthesis plus fetal requirements that can exceed 500mg/day above baseline.
Your Genotype Profile
Normal PEMT activity. Your liver synthesizes phosphatidylcholine efficiently. You have the estrogen-inducible upregulation mechanism intact. Dietary choline needs are at standard levels (~425mg/day women, ~550mg/day men per AI). You can absorb adequate choline from eggs, liver, and fish without concern.
Recommended intake: Standard AI (~425–550mg/day depending on sex). No special intervention required.
Partial PEMT impairment. One functional copy provides roughly half the endogenous synthesis capacity of GG. Premenopausal women with normal estrogen often maintain adequate function. Risk materializes during:
- Low-choline diets (vegan, low-egg, alcohol-heavy)
- Perimenopause and menopause
- Pregnancy and lactation
- Co-occurring MTHFR variants (see interaction section)
Recommended intake: 550–700mg/day from diet + supplements. Increase to 750–900mg during pregnancy.
Severe PEMT impairment. Hepatic phosphatidylcholine synthesis is substantially reduced. You are almost entirely dependent on dietary choline for liver function, membrane integrity, and cognitive acetylcholine synthesis. On a standard Western diet (which often provides only 250–350mg/day), AA homozygotes frequently meet clinical criteria for choline deficiency — even without any obvious dietary restriction.
Da Costa et al. found that AA women on a low-choline diet developed fatty liver and elevated liver enzymes within 6 weeks at rates far exceeding GG and GA women. After estrogen withdrawal (either pharmacologically or naturally via menopause), this risk becomes equivalent between sexes.
Recommended intake: 700–1000mg/day from diet + supplements. Track with DUTCH or liver function testing if symptomatic. Consult physician before pregnancy.
What Choline Deficiency Actually Looks Like
Clinical choline deficiency in PEMT variant carriers doesn't always present dramatically. The Da Costa (2006) controlled depletion trial produced measurable organ dysfunction within weeks, but in everyday life, deficiency is more often a slow drift — accumulating over years of subclinical shortfall.
Liver
- Elevated ALT/AST (hepatocellular damage)
- Hepatic fat accumulation (NAFLD)
- Impaired VLDL secretion → triglyceride retention
- Risk progression: NAFLD → NASH → fibrosis
Brain
- Reduced acetylcholine synthesis → memory gaps
- Attention and working memory difficulties
- Brain fog, particularly under cognitive load
- Accelerated age-related cognitive decline
Muscle
- Elevated CK (muscle membrane damage)
- Exercise-induced muscle breakdown
- Prolonged recovery after training
- Rhabdomyolysis risk under extreme load
Fetal Development
- Neural tube defect risk (independent of folate)
- Impaired hippocampal neurogenesis
- Reduced fetal BDNF expression
- Long-term cognitive outcome differences
The muscle damage marker (elevated CK) is particularly useful diagnostically because it's objective and appears early in controlled depletion. If you have rs7946 and exercise regularly but notice persistent soreness, slow recovery, or unexplained CK elevation on bloodwork, choline deficiency is a direct candidate cause.
Evidence-Based Interventions by Genotype
Choline Sources & Supplements — PEMT Carrier Protocol
| Source/Supplement | Choline content / dose | Mechanism | Priority for AA |
|---|---|---|---|
| Eggs (whole, cooked) | ~125mg per egg | Dietary phosphatidylcholine — best-absorbed form | Highest |
| Beef liver | ~356mg per 3oz | Highest dietary source; also provides B12, folate | Highest |
| Alpha-GPC | 300–600mg/day | Highly bioavailable; crosses blood-brain barrier; preferred for cognitive symptoms | Highest |
| CDP-Choline (citicoline) | 250–500mg/day | Converts to choline + cytidine; supports PC synthesis and uridine | High |
| Phosphatidylcholine (lecithin) | 1,200–2,400mg/day | Direct PC supplementation; best for liver VLDL support | High |
| Choline bitartrate | 500–1,000mg/day | Cost-effective bulk choline; lower CNS penetration than alpha-GPC | Moderate |
| Betaine (TMG) | 500–1,000mg/day | Choline metabolite; spares choline for other pathways; reduces PEMT SAMe burden | High |
| Methylated B vitamins | Methylfolate + methylB12 | Supports SAMe regeneration; critical for PEMT × MTHFR compound carriers | High |
Genotype-Specific Protocols
GG Protocol (Standard)
Meet standard AI through whole foods. 2–3 eggs per day + occasional fish or poultry liver gets most people there. No supplementation required unless under extreme athletic load or elimination diet.
GA Protocol (Moderate)
- · Target 550–700mg/day total choline (food + supplement)
- · 4+ eggs/day or equivalent food-first strategy
- · Add 300mg alpha-GPC if cognitive symptoms present
- · Add betaine 500mg if plant-forward diet (low dietary choline)
- · During pregnancy: increase to 750–900mg/day total; discuss with OB
- · Monitor: ALT/AST, CK annually if symptomatic
AA Protocol (High Priority)
- · Target 700–1,000mg/day total choline
- · Food-first: 4+ eggs/day + liver 1–2×/week + fatty fish
- · Alpha-GPC 300–600mg/day (cognitive support + bioavailability)
- · Phosphatidylcholine 1,200mg/day (liver VLDL support)
- · Betaine 500–1,000mg/day (methyl group sparing)
- · Methylated B vitamins (critical if also MTHFR positive)
- · If vegan: essentially impossible to meet without substantial supplementation — medical supervision recommended
- · Baseline labs: ALT, AST, CK, lipid panel (VLDL/triglycerides)
- · Pregnancy: consult OB before conception; choline demand 900mg+/day
- · Menopause: increase protocol as estrogen declines — re-evaluate dosing with each major transition
Gene Interactions: The Compounds That Amplify Risk
PEMT doesn't exist in isolation. Its function sits at the intersection of methylation, liver metabolism, and membrane synthesis — meaning it interacts with several other clinically relevant variants.
Methylation · Folate · SAMe
PEMT is an SAMe-consuming methyltransferase — it uses SAMe (S-adenosylmethionine) to methylate PE three times per PC molecule. MTHFR variants reduce the folate-methionine cycle that regenerates SAMe. When PEMT + MTHFR are both impaired, SAMe becomes simultaneously depleted by higher demand and reduced supply. This creates a compound methylation deficit that affects not just choline synthesis, but also DNA methylation, neurotransmitter synthesis (dopamine, serotonin), and detoxification. If you carry both PEMT rs7946 and MTHFR C677T, methylated B vitamins and betaine are non-negotiable.
Dopamine · SAMe competition
COMT (catechol-O-methyltransferase) also uses SAMe to inactivate catecholamines (dopamine, norepinephrine, estrogen metabolites). Slow COMT variants (Met/Met) already place higher demands on SAMe for catecholamine clearance. PEMT adds to this demand. Carriers of both slow COMT and PEMT rs7946 can have chronically low SAMe availability — manifesting as methylation inefficiency, high catecholamine sensitivity, and impaired liver PC synthesis simultaneously.
Betaine pathway · Homocysteine
BHMT uses betaine (a choline metabolite) to remethylate homocysteine back to methionine, providing an alternative SAMe regeneration pathway independent of folate. When PEMT is impaired, supplementing betaine (TMG) is particularly strategic: it both spares choline (betaine can substitute for some choline functions) and supports SAMe via the BHMT route. BHMT variants that impair this backup pathway compound PEMT risk further.
Gene expression · PEMT upregulation
Vitamin D receptor signaling has been shown to modulate PEMT gene expression in hepatocytes. VDR variants that reduce vitamin D sensitivity may reduce a secondary upregulation pathway for PEMT. This is a less established interaction, but PEMT rs7946 carriers should ensure adequate vitamin D status (50–80 ng/mL 25-OH-D) as a general liver health measure — particularly given the overlapping NAFLD risk.
The Environmental Sensitivity Lens
Applying the Belsky (2009) differential susceptibility framework to PEMT: rs7946 carriers are not damaged — they are more environmentally responsive with respect to choline availability.
On a choline-adequate diet (4+ eggs daily, regular liver or fish, betaine supplementation), PEMT AA carriers may show equivalent — or slightly superior — cellular choline handling, because their systems are calibrated to use dietary choline more efficiently when it's present. The problem arises exclusively under deficiency conditions, which is where most modern diets land.
The historical choline context matters here: traditional diets universally included organ meats, egg yolks, and fish — the highest-choline foods available. PEMT variants would have been essentially silent in that dietary context. The modern separation of eggs (feared for decades as cholesterol-raising) and the near-complete elimination of liver from most Western diets created the conditions under which PEMT variants become clinically significant.
This means your intervention is not "fix your genetics." It's "restore the dietary context your genome was calibrated for." The lever is available, accessible, and cheap.
Biomarker Monitoring
For PEMT variant carriers, these markers provide objective feedback on choline status and liver function:
Liver Function Panel
- ALT/AST: Elevated = hepatocellular stress; normalize with choline correction
- Triglycerides/VLDL: High TG with low choline = impaired VLDL secretion
- Liver ultrasound: Rule out NAFLD if ALT persistently elevated
Muscle & Methylation
- CK (creatine kinase): Elevated = muscle membrane damage; drops with choline repletion
- Homocysteine: Elevated = methylation bottleneck; address with betaine + B vitamins
- Plasma choline: Direct measure; optimal range 7–20 µmol/L
Citations
- [1]Da Costa KA, et al. Genetic risk factors for choline deficiency. Am J Clin Nutr. 2006;84:1406-1414.
- [2]Resseguie ME, et al. Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes. FASEB J. 2007;21:2622-2632.
- [3]Fischer LM, et al. Influence of choline on PEMT gene expression and the consequences for liver lipid metabolism. J Nutr Biochem. 2010;21:214-220.
- [4]Zeisel SH. Choline: critical role during fetal development and dietary requirements in adults. Annu Rev Nutr. 2006;26:229-250.
- [5]Stead LM, et al. Methylation demand and homocysteine metabolism: effects of dietary provision of methyl donors on the abundance of specific enzymes. Biochem J. 2001;354:529-538.
- [6]Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Curr Opin Gastroenterol. 2012;28:159-165.
Know Your PEMT Status
Upload your 23andMe, AncestryDNA, or whole genome file to see your PEMT rs7946 genotype — plus every other variant that affects your methylation and liver health.
Analyze Your Genome →